Filing Summary
Registrant and period: The filing is a Form 8-K for Jupiter Wellness, Inc. (Nasdaq: JUPW; warrants: JUPWW), reporting events beginning May 24, 2021 and signed May 28, 2021. The request metadata identifies BONK, INC.; this does not match the registrant named in the filing.
Material Financing Transactions
- On May 24, 2021, the company entered into a $150,000 loan agreement, consisting of a convertible promissory note and warrants to purchase 25,000 common shares. The note matures November 5, 2021.
- On May 28, 2021, the company entered into a $500,000 loan agreement, consisting of a convertible promissory note and warrants to purchase 83,334 common shares. The note matures November 19, 2021.
- Total stated principal under the two loans was $650,000. The filing does not clearly state the net cash proceeds after the original issuance discount.
Key Terms and Potential Dilution
- The notes have a 5% original issuance discount and bear interest at 8%.
- The conversion price is $6.00 per share, subject to downward adjustment to $5.00 per share if the company defaults.
- The warrants have five-year terms and a $6.00 exercise price. They include a cashless exercise feature until the underlying shares are covered by an effective registration statement and include certain anti-dilution protections.
- The transactions were reported as direct financial obligations and unregistered sales of equity securities under Items 2.03 and 3.02.
- The company relied on the Securities Act Section 4(2) and/or Regulation D exemptions from registration.
Financial Performance and Liquidity
This 8-K does not provide revenue, profit, cash flow, margin, cash balance, existing debt balances, or other operating-performance metrics. The financing provides stated principal of $650,000 but creates near-term repayment obligations and potential equity dilution.
Changes, Outlook, and Risks
- Compared with the prior comparable period, the filing does not provide financial statements or comparative operating data.
- Management guidance and forward-looking operating commentary are not provided.
- Key risks include the November 2021 maturities, 8% interest expense, default-related conversion-price reduction, potential issuance of common shares upon conversion or warrant exercise, and the absence of a clear disclosure of how the proceeds will be used.
- The filing states that the agreements are summarized and refers to exhibits filed with a May 13, 2021 Form 8-K for the full terms.
Investor Verification Points
- Confirm the correct issuer, because the filing names Jupiter Wellness, Inc., while the request metadata names BONK, INC.
- Review the May 13, 2021 Form 8-K and attached agreements for complete covenants, events of default, conversion mechanics, and registration obligations.
- Verify whether the notes were repaid, converted, refinanced, or remained outstanding at maturity.
- Determine the actual net proceeds after the 5% original issuance discount and any fees.
- Assess the potential dilution from conversion of the $650,000 notes and exercise of warrants covering 108,334 shares.